Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphangioleiomyomatosis (LAM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02654340
What this trial is testing

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Who this might be right for
Hypomelanotic MaculesFacial AngiofibromaShagreen Patches+6 more
CENTOGENE GmbH Rostock 20
Testing effectiveness (Phase 2)Study completedNCT02061397
What this trial is testing

Safety of Simvastatin in LAM and TSC

Who this might be right for
LymphangioleiomyomatosisTuberous Sclerosis Complex
University of Pennsylvania 10
Not applicableLooking for participantsNCT06160310
What this trial is testing

Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)

Who this might be right for
Tuberous Sclerosis ComplexLymphangioleiomyomatosis
David M. Ritter 300
Not applicableStudy completedNCT02009241
What this trial is testing

Pulmonary Rehabilitation in Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
University of Sao Paulo General Hospital 40
Not applicableUnknownNCT04577937
What this trial is testing

Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis

Who this might be right for
LymphangioleiomyomatosisSleep DisorderSleep Apnea Syndromes+1 more
dr. Stefano Nava 15
Not applicableLooking for participantsNCT07304856
What this trial is testing

Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex

Who this might be right for
Lymphangioleiomyomatosis (LAM)Extracellular Vesicles; Generation and Function
University of Milan 80
Not applicableStudy completedNCT00366509
What this trial is testing

Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases

Who this might be right for
Pulmonary DiseaseOropharyngeal DiseaseLymphangioleiomyomatosis+3 more
National Heart, Lung, and Blood Institute (NHLBI) 157
Testing effectiveness (Phase 2)Study completedNCT00792766
What this trial is testing

Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous SclerosisAngiolipoma
Children's Hospital Medical Center, Cincinnati 20
Large-scale testing (Phase 3)Study completedNCT00414648
What this trial is testing

Efficacy and Safety of Sirolimus in LAM

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 89
Not applicableLooking for participantsNCT05676099
What this trial is testing

TSC Biosample Repository and Natural History Database

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
National Tuberous Sclerosis Association 5,000
Testing effectiveness (Phase 2)Study completedNCT00457964
What this trial is testing

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
Children's Hospital Medical Center, Cincinnati 36
Testing effectiveness (Phase 2)Study completedNCT03062943
What this trial is testing

Nintedanib for LymphAngioleioMyomatosis (LAM)

Who this might be right for
Lymphangioleiomyomatosis
IRCCS Multimedica 30
Early research (Phase 1)Looking for participantsNCT06889168
What this trial is testing

Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)

Who this might be right for
Lymphangioleiomyomatosis (LAM)Lymphangioleiomyomatosis
Columbia University 20
Testing effectiveness (Phase 2)Study completedNCT03253913
What this trial is testing

Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 25
Testing effectiveness (Phase 2)UnknownNCT00490789
What this trial is testing

Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
Cardiff University 14
Not applicableLooking for participantsNCT02432560
What this trial is testing

Safety and Durability of Sirolimus for Treatment of LAM

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 600
Not applicableStudy completedNCT00552955
What this trial is testing

Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women

Who this might be right for
LymphangioleiomyomasTuberous SclerosisLymphangioleiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 35
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Early research (Phase 1)Study completedNCT02116712
What this trial is testing

The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)

Who this might be right for
Pulmonary Lymphangioleiomyomatosis
Tony Eissa 9
Testing effectiveness (Phase 2)Study completedNCT03131999
What this trial is testing

LAM Pilot Study With Imatinib Mesylate

Who this might be right for
Lymphangioleiomyomatosis
Medical University of South Carolina 18
Next Page